Bill tackles insulin affordability

Critics say it may require a broader scope

THE COST OF treating her Type 1 diabetes for 15 years has taken a toll on Claire Clendenen’s life. Clendenen, who works in public health in Boston, just recently paid $700 for a three-month supply of insulin. “Carrying around this huge fee on your shoulders, the cost, the accessibility, the constant fights with insurance companies,(...)

Read More »